Your browser doesn't support javascript.
loading
Maltodextrin-Nanoparticles as a Delivery System for Nasal Vaccines: A Review Article.
Fasquelle, François; Scuotto, Angelo; Howsam, Michael; Betbeder, Didier.
Afiliação
  • Fasquelle F; Vaxinano SAS, F-59120 Loos, France.
  • Scuotto A; Vaxinano SAS, F-59120 Loos, France.
  • Howsam M; Université de Lille, Inserm, Centre Hospitalier de Lille, Institut Pasteur de Lille, U1167-RID-AGE-Facteurs de Risque et Déterminants Moléculaires des Maladies Liées au Vieillissement, F-59000 Lille, France.
  • Betbeder D; Vaxinano SAS, F-59120 Loos, France.
Pharmaceutics ; 16(2)2024 Feb 07.
Article em En | MEDLINE | ID: mdl-38399301
ABSTRACT
Nanoparticles are increasingly being studied as antigen delivery systems for immunization with nasal vaccines. The addition of adjuvants is still generally required in many nanoparticle formulations, which can induce potential side effects owing to mucosal reactogenicity. In contrast, maltodextrin nanoparticles do not require additional immunomodulators, and have been shown to be efficient vaccine delivery systems. In this review, the development of maltodextrin nanoparticles is presented, specifically their physico-chemical properties, their ability to load antigens and deliver them into airway mucosal cells, and the extent to which they trigger protective immune responses against bacterial, viral, and parasitic infections. We demonstrate that the addition of lipids to maltodextrin nanoparticles increases their potency as a vaccine delivery system for nasal administration.
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Ano de publicação: 2024 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Ano de publicação: 2024 Tipo de documento: Article